- Home
- SFST vs ABEO Comparison
SFST vs ABEO Comparison
Compare SFST & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SFST | ABEO |
|---|---|---|
| Founded | 1999 | 1974 |
| Country | United States | United States |
| Employees | 297 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.9M | 281.0M |
| IPO Year | 1999 | 1980 |
Fundamental Metrics
Financial Performance| Metric | SFST | ABEO |
|---|---|---|
| Price | $51.67 | $5.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $51.00 | $18.20 |
| AVG Volume (30 Days) | 65.8K | ★ 1.1M |
| Earning Date | 01-27-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.78 | N/A |
| EPS | ★ 3.23 | 1.29 |
| Revenue | ★ $109,391,000.00 | $400,000.00 |
| Revenue This Year | $14.65 | N/A |
| Revenue Next Year | $20.61 | $1,589.77 |
| P/E Ratio | $15.95 | ★ $4.10 |
| Revenue Growth | ★ 21.32 | N/A |
| 52 Week Low | $29.14 | $3.93 |
| 52 Week High | $56.73 | $7.54 |
Technical Indicators
Market Signals| Indicator | SFST | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 54.91 |
| Support Level | $54.64 | $4.80 |
| Resistance Level | $56.10 | $5.55 |
| Average True Range (ATR) | 1.17 | 0.24 |
| MACD | -0.59 | 0.01 |
| Stochastic Oscillator | 5.73 | 66.03 |
Price Performance
Historical ComparisonAbout SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.